Husain Qasim, Joshi Rohan R, Cracchiolo Jennifer R, Roman Benjamin R, Ganly Ian, Tabar Viviane, Cohen Marc A
Department of Otolaryngology - Head and Neck Surgery, Columbia University Medical Center, New York, New York, United States.
Department of Otolaryngology - Head and Neck Surgery, Weill Cornell Medical College, New York, New York, United States.
J Neurol Surg B Skull Base. 2019 Aug;80(4):371-379. doi: 10.1055/s-0038-1675233. Epub 2018 Oct 25.
Determining surgical trends and outcomes for sinonasal tumors is challenging given their low incidence and heterogeneous pathology. This study utilized the National Cancer Database (NCDB) to identify trends and outcomes associated with surgical management of sinonasal tumors. Retrospective database analysis. National Cancer Database. Patients with sinonasal malignancies identified from the NCDB between 2010 and 2015. The primary outcome was the choice of surgical therapy used for sinonasal tumor resection: endoscopic versus open approach. Each was cohort analyzed with respect to various demographic and clinicopathologic factors. A treatment effect model was used to identify potential differences between surgical approaches. Survival was evaluated using Kaplan-Meier analysis. A total of 10,193 patients with sinonasal malignancies were identified in the NCDB database; of these, 2,292 had a documented subsite, histology, and definitive surgical treatment with documented surgical approach and were included in the analysis. About 71.9% of patients had an open approach and 28.1% a purely endoscopic procedures. Tumor histology, treatment facility type, margin status, and length of stay were all variables that were associated with significant differences between the open and endoscopic cohort. Five-year survival rates for the open and endoscopic cohorts were not significantly different (59.6 and 60.8%, respectively). Assessment of the NCDB revealed that 28% patients with sinonasal malignancy were selected for endoscopic surgery. These patients had comparable oncologic outcomes to open resection.
鉴于鼻窦肿瘤发病率低且病理异质性大,确定其手术趋势和治疗结果具有挑战性。本研究利用国家癌症数据库(NCDB)来确定与鼻窦肿瘤手术治疗相关的趋势和结果。
回顾性数据库分析。
国家癌症数据库。
2010年至2015年间从NCDB中识别出的鼻窦恶性肿瘤患者。
主要结果是用于鼻窦肿瘤切除的手术治疗选择:内镜手术与开放手术。对每组患者的各种人口统计学和临床病理因素进行分析。使用治疗效果模型来识别手术方法之间的潜在差异。采用Kaplan-Meier分析评估生存率。
在NCDB数据库中总共识别出10193例鼻窦恶性肿瘤患者;其中,2292例有记录的亚部位、组织学以及明确的手术治疗且有记录的手术方法,并纳入分析。约71.9%的患者采用开放手术,28.1%的患者采用单纯内镜手术。肿瘤组织学、治疗机构类型、切缘状态和住院时间都是与开放手术组和内镜手术组之间存在显著差异相关的变量。开放手术组和内镜手术组的五年生存率无显著差异(分别为59.6%和60.8%)。
对NCDB的评估显示,28%的鼻窦恶性肿瘤患者选择了内镜手术。这些患者的肿瘤学结果与开放手术切除相当。